News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Alberto Hernando-Calvo: Durvalumab with Olaparib or Cediranib in patients with pMMR CRC or Pancreatic Cancer
Photo taken from Alberto Hernando-Calvo/X
Jul 11, 2024, 10:49

Alberto Hernando-Calvo: Durvalumab with Olaparib or Cediranib in patients with pMMR CRC or Pancreatic Cancer

Alberto Hernando-Calvo, Clinician scientist at Vall d’Hebron Barcelona Hospital, shared on X:

“Phase II, open-label, randomized trial of durvalumab with olaparib or cediranib in patients with proficient mismatch repair (pMMR) Colorectal Cancer (CRC) or pancreatic cancer at Princess Margaret Cancer Centre. Mentorship from Aaron Hansen and Lillian Siu and support from Pugh Lab, Benjamin Haibe-Kains labs, Ontario Institute for Cancer Research and others!”

A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair—Proficient Colorectal or Pancreatic Cancer

Authors: Alberto Hernando-Calvo, Ming Han, Olubukola Ayodele, Ben X. Wang, Jeffrey P. Bruce, Farnoosh Abbas-Aghababazadeh, Maria Vila-Casadesús, Enrique Sanz-Garcia, S.Y. Cindy Yang, Hal K. Berman, Ana Vivancos, Bernard Lam, Ilinca Lungu, Abdulazeez Salawu, Lee-Anne Stayner, Benjamin Haibe-Kains, Philippe L. Bedard, Lisa Avery, Albiruni R.A. Razak, Trevor J. Pugh, Anna Spreafico, Lillian L. Siu, Aaron R. Hansen.

Alberto Hernando-Calvo: Durvalumab with Olaparib or Cediranib in patients with pMMR CRC or Pancreatic Cancer

Source: Alberto Hernando-Calvo/X

Aaron Hansen Aaron R. Hansen Abdulazeez Salawu Alberto Hernando Calvo Albiruni R.A. Razak Ana Vivancos Anna Spreafico Ben X. Wang Benjamin Haibe-Kains Benjamin Haibe-Kains labs Bernard Lam cancer cediranib colorectal cancer CRC Durvalumab Enrique Sanz-Garcia Farnoosh Abbas-Aghababazadeh Hal K. Berman Ilinca Lungu Jeffrey P. Bruce Lee-Anne Stayner Lillian L. Siu Lisa Avery Maria Vila-Casadesús Ming Han olaparib Olubukola Ayodele OncoDaily Oncology Ontario Institute for Cancer Research Pancreatic Cancer Philippe L. Bedard Princess Margaret Cancer Centre Pugh Lab S.Y. Cindy Yang Trevor J. Pugh Vall d'Hebron Barcelona Hospital
Special Coverage
Blog
Mar 29, 2025, 04:55
Akhil Santhosh: Final overall survival results of checkmate 067 in NEJM
Blog
Mar 29, 2025, 04:16
Maximilian Merz: From student to academic physician - A 14-Year Journey at MSKCC
OncoDaily Pulse
Mar 29, 2025, 03:34
OncoDaily partners with EYOC aiming for innovation, research and equitable care
Career
Mar 29, 2025, 03:20
Nasim Eftekhari: I've been promoted to Chief AI and Analytics Officer at City of Hope
Insight
Mar 28, 2025, 20:51
Samer Al Hadidi: Check out our recent work in Blood Advances, led by Bhavesh Mohan Lal at the UAMS Myeloma Center
Blog
Mar 28, 2025, 20:17
Mustafa H. Alsaadi: Excited to share that three of our abstracts have been accepted for poster presentation at ASCO 2025
Blog
Mar 28, 2025, 20:11
Raffaele Giusti: MARIPOSA overall survival data at ELCC25
Blog
Mar 28, 2025, 19:58
Nina Niu Sanford: Here is HCC 101 video
Blog
Mar 28, 2025, 19:38
Julien Mazieres: Another brick in the wall of HER2-mutant NSCLC
Blog
Mar 28, 2025, 19:18
Liz Main Morrison: Not long until MPs vote on the Tobacco and Vapes Bill that will mean kids like Henry can never legally smoke
Blog
Mar 28, 2025, 18:51
Mukhtar Malcolm Alkali: I had the honor of representing Medicaid CF Programs at the grand launch of BRANT Program
Blog
Mar 28, 2025, 18:22
ESH-iCMLf 27th Annual John Goldman Conference on CML - European School of Haematology